^
BIOMARKER:

TYRO3 mutation + ALK mutation

i
Other names: TYRO3, TYRO3 Protein Tyrosine Kinase, Tyrosine-Protein Kinase Receptor TYRO3, Tyrosine-Protein Kinase DTK, Tyrosine-Protein Kinase RSE, Tyrosine-Protein Kinase SKY, Tyrosine-Protein Kinase TIF, Etk-2, BYK, Dtk, RSE, Rek, Sky, Tif, Tyrosine-Protein Kinase Byk, Tyrosine-Protein Kinase BYK, TYRO3, Brt, DTK, SKY, TIF, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma R
Entrez ID:
News
Twitter
Trials
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
sunitinib
Sensitive: D – Preclinical
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
crizotinib + sunitinib
Sensitive: D – Preclinical
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
crizotinib
Resistant: D – Preclinical